Kenneth C. Frazier

Director

Director at Eikon Therapeutics, Inc., filing insider transactions on 2026-02-04.

Total Purchases

$2.0M

1 transaction

Total Sales

—

0 transactions

Companies Traded

1

1 total filings

Active Since

2026-02-04

Last: 2026-02-04

Companies

Eikon Therapeutics, Inc.

Other Reporting Insiders at Eikon Therapeutics, Inc.

Transaction History

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-02-04	EIKN	Purchase	111.1K	$18.00	$2.0M	111.1K	SEC ↗

Kenneth C. Frazier (Eikon Therapeutics, Inc.) Insider Trades | Tormere